drug
ATSN-201
Phase 3updated 6mo agoby Atsena Therapeutics Inc
Phase 3community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying ATSN-201
News(1)
- Atsena’s Lighthouse gene therapy readout illuminates eye disease efficacyAtsena Therapeutics has reported evidence of efficacy in a clinical trial of an eye disease gene therapy, encouraging the biotech to forge ahead with a study that could support a filing for approva…fiercebiotech · 1mo ago
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that